Q: Hi 5i,
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.